| Wal-mart Pharmacy 10-1202 | |
| 4331 8th St S, Wisconsin Rapids, Wisconsin 54494 | |
| (715) 423-8500 |
| Name | Wal-mart Pharmacy 10-1202 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 4331 8th St S, Wisconsin Rapids, Wisconsin 54494 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (715) 423-8500 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Patients with coronary artery disease undergoing stent implantation are often prescribed the antiplatelet drug, clopidogrel. This drug prevents blood clots, but is known to have a side-effect that can cause stomach bleeding. Consequently, many users are also prescribed a proton pump inhibitor (PPI). Now, however, a meta-analysis of almost 160,000 patients carried out at the Medical University of Vienna and Wilhelminenhospital, Vienna, has shown that simultaneous use of these drugs can increase the risk of cardiac damage.
Disclosure this week of a sixth case in the United States of a new viral infection emerging from China — and the first confirmed case of the virus passing from person to person in this country — is fueling public concerns about how easily the deadly virus can spread.
Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study by researchers at Rush University Medical Center.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).
A study conducted by an international research team, which included investigators from Seattle Children's Research Institute, implicates variants in four genes as a primary cause of non-syndromic cleft lip and palate in humans.
› Verified 8 days ago
| NPI Number | 1508884206 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WAL-MART PHARMACY 10-1202 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4331 8th St S, Wisconsin Rapids, WI 54494 |
| Phone Number | 715-423-8500 |
News Archive
Patients with coronary artery disease undergoing stent implantation are often prescribed the antiplatelet drug, clopidogrel. This drug prevents blood clots, but is known to have a side-effect that can cause stomach bleeding. Consequently, many users are also prescribed a proton pump inhibitor (PPI). Now, however, a meta-analysis of almost 160,000 patients carried out at the Medical University of Vienna and Wilhelminenhospital, Vienna, has shown that simultaneous use of these drugs can increase the risk of cardiac damage.
Disclosure this week of a sixth case in the United States of a new viral infection emerging from China — and the first confirmed case of the virus passing from person to person in this country — is fueling public concerns about how easily the deadly virus can spread.
Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study by researchers at Rush University Medical Center.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).
A study conducted by an international research team, which included investigators from Seattle Children's Research Institute, implicates variants in four genes as a primary cause of non-syndromic cleft lip and palate in humans.
› Verified 8 days ago
News Archive
Patients with coronary artery disease undergoing stent implantation are often prescribed the antiplatelet drug, clopidogrel. This drug prevents blood clots, but is known to have a side-effect that can cause stomach bleeding. Consequently, many users are also prescribed a proton pump inhibitor (PPI). Now, however, a meta-analysis of almost 160,000 patients carried out at the Medical University of Vienna and Wilhelminenhospital, Vienna, has shown that simultaneous use of these drugs can increase the risk of cardiac damage.
Disclosure this week of a sixth case in the United States of a new viral infection emerging from China — and the first confirmed case of the virus passing from person to person in this country — is fueling public concerns about how easily the deadly virus can spread.
Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study by researchers at Rush University Medical Center.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).
A study conducted by an international research team, which included investigators from Seattle Children's Research Institute, implicates variants in four genes as a primary cause of non-syndromic cleft lip and palate in humans.
› Verified 8 days ago
Rapid Rehab Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2660 8th St S, Wisconsin Rapids, Wisconsin 54494 Phone: (715) 423-2084 | |
Cvs Pharmacy #10163 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2410 8th St S, Wisconsin Rapids, Wisconsin 54494 Phone: (715) 423-2340 | |
Walgreens #9009 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3200 8th St S, Wisconsin Rapids, Wisconsin 54494 Phone: (715) 424-4082 | |
Wal-mart Pharmacy 10-1202 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4331 8th St S, Wisconsin Rapids, Wisconsin 54494 Phone: (715) 423-8500 | |
Daly Drug Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3215 8th Street South, Wisconsin Rapids, Wisconsin 54494 Phone: (715) 423-3400 |